PACAP is hét platform voor lange termijn onderzoek
naar de behandeling en (patiënt gerapporteerde)
uitkomsten van alvleesklierkanker
deelnemende
centra
patiënten in
PACAP PROMs
patiënten in
PACAP cohort
There is often an overlap in both questionnaires and patient population in PACAP PROMs and other projects. By collaborating, we avoid that patients fill in questionnaires twice. PACAP collaborates with the following studies.
TIMEPAN
15 september 2022
Timing of start of systemIc treatment for asymptomatic MEtastasized PANcreatic cancer (TIMEPAN): a randomized controlled multicenter trial
Read moreRADAR-PANC
15 september 2022
Recurrent Disease Detection after Resection of Pancreatic Adenocarcinoma using a Standardized Surveillance Strategy (RADAR-PANC): a nationwide, randomized controlled trial
Read morePREOPANC-3
15 september 2022
Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer
Read morePANCOSAR
15 september 2022
Stereotactic Radiotherapy vs Best Supportive Care in Unfit Pancreatic Cancer Patients
Read moreARCADE
15 september 2022
Additional Treatment for Isolated Local Pancreatic Cancer Recurrence Using Stereotactic Body Radiation Therapy
Read moreDIPLOMA-2
15 september 2022
Minimally invasive versus open pancreatoduodenectomy for pancreatic and periampullary neoplasms
Read morePREOPANC-4
15 september 2022
Nationwide implementation program for optimal multidisciplinary management and resection of locally advanced pancreatic cancer.
Read moreDIPLOMA
15 maart 2021
Distal pancreatectomy, minimally invasive or open, for malignancy: a Pan-European randomized multicenter study
Read morePANFIRE-III
18 maart 2021
Study investigating treatment with IRE (nanoknife) of the primary tumor whether or not in combination with immunotherapy in inoperable pancreatic patients with liver metastases
Read morePEGASUS
14 maart 2021
Study investigating treatment with IRE (nanoknife) of the primary tumor whether or not in combination with immunotherapy in inoperable pancreatic patients with liver metastases
Read morePREOPANC-2
13 maart 2021
Neoadjuvant FOLFIRINOX versus neoadjuvant chemoradiotherapy and adjuvant chemotherapy for (borderline) resectable pancreatic carcinoma
Read moreeQuiPe
12 maart 2021
How do patients with advanced cancer and their loved ones experience quality of life and quality of care
Read more
